KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Exchange Rate Effect: 2018-2025

Historic Exchange Rate Effect for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to -$533,000.

  • Guardant Health's Exchange Rate Effect fell 128.05% to -$533,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$518,000, marking a year-over-year decrease of 154.24%. This contributed to the annual value of -$1.8 million for FY2024, which is 94.29% down from last year.
  • Guardant Health's Exchange Rate Effect amounted to -$533,000 in Q3 2025, which was down 156.88% from $937,000 recorded in Q2 2025.
  • Guardant Health's 5-year Exchange Rate Effect high stood at $1.9 million for Q3 2024, and its period low was -$1.7 million during Q4 2024.
  • For the 3-year period, Guardant Health's Exchange Rate Effect averaged around -$136,727, with its median value being -$526,000 (2023).
  • As far as peak fluctuations go, Guardant Health's Exchange Rate Effect plummeted by 20,371.43% in 2022, and later spiked by 461.22% in 2024.
  • Guardant Health's Exchange Rate Effect (Quarterly) stood at -$500,000 in 2021, then surged by 328.00% to $1.1 million in 2022, then dropped by 9.65% to $1.0 million in 2023, then plummeted by 264.56% to -$1.7 million in 2024, then tumbled by 128.05% to -$533,000 in 2025.
  • Its Exchange Rate Effect was -$533,000 in Q3 2025, compared to $937,000 in Q2 2025 and $773,000 in Q1 2025.